Skip to main content
ALNY logo

ALNY

Alnylam Pharmaceuticals, Inc.
$312.78 +11.11 (+3.68%) At close · Jul 2
Market Cap
$41.48B
Shares
132,623,144

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 786
Total Value: $41,009,574,422
Total Shares: 123,944,729
Showing 1–100 of 815 holdings by value · page 1 of 9

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 789 13F filers
Top Holder
11.8%
Jun 2023 → Mar 2026 · range 10.7% – 13.9%
of institutional value
Top 5
41.6%
Jun 2023 → Mar 2026 · range 41.6% – 47.9%
of institutional value
Top 10
57.5%
Jun 2023 → Mar 2026 · range 57.5% – 64.7%
of institutional value
HHI
453
Jun 2023 → Mar 2026 · range 453 – 581
Broadly held
Showing 100 of 815
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1178670 CUSIP 02043Q107 13F (30d) 26 filings 6 filers Visit website Investor relations